Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ex-NIH boss is new R&D head at Sanofi-Aventis

This article was originally published in Scrip

Executive Summary

Dr Elias Zerhouni has been appointed president of global R&D at Sanofi-Aventis, which covers medicines and vaccines, effective 1 January. Dr Marc Cluzel is resigning as executive vice president of R&D at the company but will continue in an advisory capacity for the time-being. Dr Zerhouni has been scientific advisor to CEO Christopher Viehbacher since February 2009. In October 2008 he stepped down as the director of the US NIH after more than six years in the position. He is currently professor of radiology and biomedical engineering at the John Hopkins University and Hospital (US).



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts